A61K 31/501
Not condensed and containing further heterocyclic rings
Official title: not condensed and containing further heterocyclic rings
A61K31/501 (Not condensed and containing further heterocyclic rings) appears on 1,291 US grants and 2,497 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,291
- Published applications
- 2,497
- Assignees
- 862
- Inventors
- 6,650
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 6 | 0 |
| 2001 | 2 | 3 |
| 2002 | 5 | 16 |
| 2003 | 9 | 54 |
| 2004 | 28 | 68 |
| 2005 | 15 | 28 |
| 2006 | 48 | 56 |
| 2007 | 13 | 35 |
| 2008 | 22 | 38 |
| 2009 | 21 | 30 |
| 2010 | 25 | 51 |
| 2011 | 24 | 44 |
| 2012 | 29 | 54 |
| 2013 | 42 | 93 |
| 2014 | 62 | 105 |
| 2015 | 76 | 124 |
| 2016 | 84 | 126 |
| 2017 | 111 | 131 |
| 2018 | 74 | 129 |
| 2019 | 102 | 108 |
| 2020 | 82 | 118 |
| 2021 | 80 | 135 |
| 2022 | 56 | 109 |
| 2023 | 64 | 129 |
| 2024 | 66 | 244 |
| 2025 | 76 | 244 |
| 2026 | 61 | 225 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Dosage forms for TYK2 inhibitors6 Oct 2026US 12,751,948 B2Bristol-Myers Squibb Company
- Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesviruses6 Oct 2026US 12,753,187 B2Merck Sharp & Dohme Corp.
- N2-arylmethyl-4-haloalkyl-pyridazin-3-one CFTR modulators for the treatment of cystic fibrosis29 Sep 2026US 12,747,215 B2Centre National de la Recherche Scientifique (CNRS)
- Dosage forms for Tyk2 inhibitors15 Sep 2026US 12,734,169 B2Bristol-Myers Squibb Company
- PAI-1 inhibitors and uses thereof15 Sep 2026US 12,735,402 B2The Cleveland Clinic Foundation
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Cis-8-(3,5-Difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]decan-2-one derivatives8 Oct 2026US 2026/0308140 A1Gruenenthal GmbH
- Lysine acetyltransferase 6a (kat6a) inhibitor, combinations and uses thereof1 Oct 2026US 2026/0294884 A1Insilico Medicine IP Limited
- Tablet comprising 6-((5-methyl-3-(6-methylpyridin-3-yl)isoxazol-4-yl)methoxy)- n-(tetrahydrapyran-4-yl)pyridazine-3-carboxamide1 Oct 2026US 2026/0294904 A1Hoffmann-La Roche Inc.
- Aromatic substituent-containing (hetero) aryl-imidazole compound, and preparation method therefor and use thereof1 Oct 2026US 2026/0297065 A1Open Source Therapeutics
Most cited
By later US patents
- Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction140US 6,037,346 AVivus, Inc. · 2000
- Pyrazole compositions useful as inhibitors of ERK126US 6,784,195 B2Vertex Pharmaceuticals Incorporated · 2004
- Modulators of ATP-binding cassette transporters124US 7,659,268 B2Vertex Pharmaceuticals Incorporated · 2010
- Delivery of erectile dysfunction drugs through an inhalation route120US 6,803,031 B2Alexza Molecular Delivery Corporation · 2004
- Modulators of ATP-binding cassette transporters116US 7,741,321 B2Vertex Pharmaceuticals Incorporated · 2010